X-ZELL CEO to speak at Bio Pitch & Partner Conference

Bangkok, September 2017 – Dr Sebastian Bhakdi, founder and CEO of Bangkok-based medical technology company X-ZELL, has been confirmed as the keynote speaker for the 2017 Bio Pitch & Partner Conference, which will be held as part of the Thailand LAB 2017 exhibition.

Based out of Bangkok, Thailand, X-ZELL is a Silicon Valley backed start-up specialising in early cancer detection that is working on novel technology to identify and visualise circulating atypical cells, among them ultra-rare tumour-associated circulating endothelial cells (tCEC), in non- and minimally invasive sample material such as blood or lung fluid.

Dr Bhakdi will use his keynote speech to give the audience an exclusive ‘behind the scenes’ tour of X-ZELL and reflect on the long and testing journey that saw a one-man research lab grow into a globally positioned start-up with a game-changing future vision.

He will also give a sneak peek at the world’s first tCEC-based cancer diagnostics study designed in collaboration with Mahidol University’s Siriraj Hospital in Bangkok, as well as a 1,000 patient study backed by the Thailand Research Fund (TRF).

Thailand LAB 2017 will be held from 6-8 September 2017 at the Bangkok International Trade & Exhibition Centre (BITEC).

Dr Bhakdi’s keynote speech will be part of the two-day Bio Pitch & Partner Conference and take place on 7 September at 10:30am in Conference Room A. He will be available for a limited number of media interviews following his presentation. Please register your interest as per contact below.

Sebastian Grote
Head of Marketing & Communications
media@x-zell.com

X-ZELL
Next-generation cytology

© 2023 X-ZELL INC

Find Us

XZELL HQ